Orthofix to Report Third Quarter 2026 Financial Results
Orthofix pays former executives $24M in damages
Orthofix Medical Sees Reimbursement Rebound, but Spine Slump Clouds Outlook
Orthofix (OFIX) Q2 2026 Earnings Call Transcript
Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $13
Orthofix Medical Inc (OFIX) (Q2 2026) Earnings Call Highlights: Strategic Moves and Raised ...
Orthofix Medical Q2 Earnings Call Highlights
Orthofix Medical (NASDAQ:OFIX) Jumps on Q2 Earnings Beat and Raised Guidance
Orthofix Medical Inc. (OFIX) Q2 2026 Earnings Call Transcript
Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress
Orthofix Medical Inc. 2026 Q2 - Results - Earnings Call Presentation
Orthofix Medical Raises FY2026 Sales Guidance from $838.000M-$848.000M to $845.000M-$855.000M vs $843.311M Est
Orthofix Medical Q2 Adj. EPS $0.07 Beats $(0.41) Estimate, Sales $210.933M Beat $209.277M Estimate
Orthofix Medical (OFIX) Looks Attractive After CMS Reversed Its Reimbursement
Wall Street Analysts Think Orthofix (OFIX) Could Surge 33.28%: Read This Before Placing a Bet
Orthofix to Participate in Upcoming Investor Conferences
Orthofix to Report Second Quarter 2026 Financial Results
Reported July 2, 2026: Orthofix Medical Says Medicare Will Restore Pre-May 18 Reimbursement Rates For Bone Growth Stimulators After CMS Reversal
Orthofix Medical (OFIX) Among the Best Small-Cap Growth Stocks To Buy Now
Orthofix Medical (OFIX) Stock Sees Split Analyst Revisions After CMS Reimbursement Reset
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.